TIRmed Pharma (private company)

See something wrong or missing? Let us know
Offices:
Stockholm
Registration number:
559149-0213
Business model:
B2B
Investors:
we tracked 1 investor
You need an account to access this feature. Login or create one from here. (it takes 20 seconds)

Total investments received (USD) - we tracked 1 transaction

You need an account to access this feature. Login or create one from here. (it takes 20 seconds)

TIRmed Pharma is developing a next generation topical treatment of eczema (atopic dermatitis) for mild to moderate symptoms. TIRmed Pharma´s product is a non-steroid cream that dampens inflammation and relieves itch.

Companies with similar profile to TIRmed Pharma:

CompanyCriteria
Sweden Inossia
54%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • At least one other investor: Almi Invest
  • Total raised in a similar range: < 1M USD
Sweden Gnosco
54%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • At least one other investor: Almi Invest
  • Total raised in a similar range: < 1M USD
Sweden Gradientech
44%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • At least one other investor: Almi Invest
Iceland 3Z Pharmaceuticals
44%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Total raised in a similar range: < 1M USD
Finland Causalus
44%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Total raised in a similar range: < 1M USD
Sweden Beactica
44%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • At least one other investor: Almi Invest
Sweden PharmNovo
44%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • At least one other investor: Almi Invest
Iceland geoSilica
44%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Total raised in a similar range: < 1M USD
Sweden Monivent
43%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one other investor: Almi Invest
  • Total raised in a similar range: < 1M USD
Sweden Bonvisi AB
43%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one other investor: Almi Invest
  • Total raised in a similar range: < 1M USD
Sweden Nosa
43%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one other investor: Almi Invest
  • Total raised in a similar range: < 1M USD
Sweden VOC Diagnostics
43%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one other investor: Almi Invest
  • Total raised in a similar range: < 1M USD
Sweden Celluminova
43%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one other investor: Almi Invest
  • Total raised in a similar range: < 1M USD
Sweden PressCise AB
43%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one other investor: Almi Invest
  • Total raised in a similar range: < 1M USD
Sweden Merozyne Therapeutics
43%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one other investor: Almi Invest
  • Total raised in a similar range: < 1M USD
Sweden MedFilm
43%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one other investor: Almi Invest
  • Total raised in a similar range: < 1M USD
Sweden Mindmore
43%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one other investor: Almi Invest
  • Total raised in a similar range: < 1M USD
Sweden BiBB Instruments
43%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one other investor: Almi Invest
  • Total raised in a similar range: < 1M USD
Sweden PeptiSystems
43%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one other investor: Almi Invest
  • Total raised in a similar range: < 1M USD
Sweden Amferia
43%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one other investor: Almi Invest
  • Total raised in a similar range: < 1M USD